Toxicity of 1,25-dihydroxyvitamin d3, tacalcitol, and calcipotriol after topical treatment in rats

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 1, 1996, Pages 60-63

  Mortensen, Jens Tiling ^a,b   Lichtenberg, Jens ^a   Binderup, Lise ^a  

^a LEO PHARMA A S   (Denmark)

^b NONE   (Denmark)

Author keywords

Hypercalcemialpsoriasis; Vitamin d analogs

Indexed keywords

1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; CALCIPOTRIOL; CALCITRIOL; CALCIUM; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE; PARATHYROID HORMONE;

ANIMAL; ARTICLE; BLOOD; FEMALE; LEWIS RAT; METABOLISM; MOUSE; RAT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CALCITRIOL; CALCIUM; DIHYDROXYCHOLECALCIFEROLS; FEMALE; MICE; PARATHYROID HORMONE; RATS; RATS, INBRED LEW;

EID: 0030112258     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Agus ZS, Goldfarb S, Wasserstein A: Calcium transport in the kidney. Rev Physiol Kochern Pharmacol 90:155-169, 1981
2. Barber ED, Teetsel NM, Kolberg KF, Guest D: A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. Funiam Appl Toxicol 19:493-497, 1992
3. Dartek MJ, LaDudde JA, Maibach HI: Skin permeability in vivo-, comparison in rat, rabbit, pig and man. J Invest Domatol 58:114-123, 1972
4. 3: effects of cell growth regulation in vitro and calcium metabolism in vivo. Phannacol Toxicol 72:240-244, 1993
5. Binderup L, Bramm E: Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo, Biochem Phannacol 37:889-895, 1988
6. Bouillon R, Allewaert K, Xiang DZ, Tan BK, van Baelen H: Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Dont Mhur Res 6:1051-1057, 1991
7. Habener JF, Potts JT Jr: Fundamental considerations in the physiology', biology, and biochemistry of parathyroid hormone. In: Avioli LV, Krane SM (eds.). Metabolic Bout Disease and Clinically Related Disorders. WE Saunders, Philadelphia, 1990, pp 69-130
8. 3 analogue, 1 of,24-dihydroxycholccalciferol. BrJ Dcrmatol 115:431-433, 1986
9. Kawashima H, Hishina K, Hashimoto Y, Takeshita T, Ishimoto S, Noguchi T, Ikekawa N, Morisaki M, Orimo H: Biological activity of la,24-dihydroxycholccalciferol; a new synthetic analog of the hormonal form of vitamin D. FERS Lett 76:177-181, 1977
10. 3. Bioclam Pharmacol 41:1601-1606, 1991
11. Mars YWUM, Lemmens AG, Beynen AC: Dietary phosphorus and nephrocalcinosis in female rats. Kutr Rep Ii:t 38:249-258, 1988
12. 3 with high activity for inducing epidermal differentiation but decreased hypercalcémie activity. J Dennatol 17:135-142, 1990
13. Morrissey R: Renal calcifications, mouse. In: Jones TC, Mohr U, Hunt RD (eds.). Urinary System (Monographs on Pathology of Laboratory Animals). Springer-Verlag, Berlin, 1986, pp 361-364
14. 3 in the parathyroid ill vivo.J Clin Im'est 86:1968-1975, 1990
15. Nguyen HT, Woodard JC: Intranephronic calculosis in rats, -liii J Palliol 100:39-56, 1980
16. Ritskes-Hoitinga J, Lemmens AG, Beyncn AC: Nutrition and kidney calcification in rats. Lab Anim 23:313-318, 1989
17. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM: Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78:1296-1301, 1986
18. Sorensen H, Binderup L, Calverley MJ, Hoffmeyer L, Andersen NR: In vitro metabolism of Calcipotriol (MC 903), a vitamin D analogue. Biochcm Phannacol 39:391-393, 1990
19. Stem PH, Bell NH: Disorders of vitamin D metabolism-toxicity and hypcrscnsitivity. In: Tarn CS (ed.). Metabolic Bone Diseases: Cellular and Tissue Mechanisms. CRC Press, Boca Raton, FL, 1989, pp 203-213
20. Vieth R: The mechanisms of vitamin D toxicity. Bone Miner 11:267-272, 1990
21. Wester RC, Noonan PK: Relevance of animal models for percutaneous absorption. Int J Pliarmacenl 7:99-110, 1980